Back

Why and how should we use 3D echo in: heart valve diseases?

6 December 2017 (14:45 - 15:07)
Organised by:
Congress Presentation Part of: Clinical use of 3D echo to assess ventricular geometry and function The imaging examination and quality assessment EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Professor Nina Ajmone Marsan

Leiden University Medical Center, Leiden (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Why and how should we use 3D echo in: right heart disease.
Doctor J. Morales Portano (Mexico City, MX)
Slides Video
Presentation thumbnail
Why and how should we use 3D echo in: heart failure?
Doctor S. Kapetanakis (London, GB)
Slides Video
Presentation thumbnail
Why and how should we use 3D echo in: cancer patients treated with potentially cardiotoxic drugs?
Professor M. Monaghan (London, GB)

Access the full session

Session thumbnail
Clinical use of 3D echo to assess ventricular geometry and function

The Event

Event poster

EuroEcho-Imaging 2017

6 December 2017 14:45 CET
You may be interested in
thumbnail
Congress Presentation
Congenital defects of the atrio-ventricular valves: the additional value of 3D/4D echocardiography
13 December 2025
thumbnail
Webinar
Structural heart interventions in aortic valvular disease - IC Core Curriculum 2
4 May 2022
thumbnail
Congress Presentation
Usefullness of 2D/3D-TEE for guiding transapical beating heart neochordae implantation in mitral regurgitation.
27 August 2021
thumbnail
Congress Presentation
The evolving role of cardiac myosin inhibitors in obstructive HCM
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources